Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Armstrong

Showing results (951-960 of 1,035) with videos related to

Pageof 104
Sort By:
JAMA Dermatology|November 3, 2021
Association Between Melanoma Detected During Routine Skin Checks and MortalityCaroline G Watts, Kirstie McLoughlin, Chris Goumas, et al.
Plos One|April 25, 2009
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma riskSophia S Wang, Mark P Purdue, James R Cerhan, et al.
Gynecologic Oncology|August 16, 2017
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experienceKate E Oliver, William E Brady, Michael Birrer, et al.
Contemporary Clinical Trials|March 8, 2021
Predicting deseasonalised serum 25 hydroxy vitamin D concentrations in the D-Health Trial: An analysis using boosted regression treesMary Waterhouse, Catherine Baxter, Briony Duarte Romero, et al.
JCO Oncology Practice|July 1, 2020
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific ApproachJennifer Y Sheng, Cesar A Santa-Maria, Neha Mangini, et al.
The Journal of Investigative Dermatology|January 16, 2007
CDKN2A germline mutations in individuals with cutaneous malignant melanomaIrene Orlow, Colin B Begg, Javier Cotignola, et al.
Carcinogenesis|November 26, 2008
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphomaMark P Purdue, Qing Lan, Sophia S Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2020
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i> Mutations: Results of the NCI-MATCH Trial Subprotocol HApril K S Salama, Shuli Li, Erin R Macrae, et al.
Breast Cancer Research and Treatment|November 15, 2011
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerMichaela J Higgins, Tatiana M Prowell, Amanda L Blackford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma studyNancy E Thomas, Klaus J Busam, Lynn From, et al.
Pageof 104

Showing results (951-960 of 1,035) with videos related to

Sort By:
Pageof 104
JAMA Dermatology|November 3, 2021
Association Between Melanoma Detected During Routine Skin Checks and MortalityCaroline G Watts, Kirstie McLoughlin, Chris Goumas, et al.
Plos One|April 25, 2009
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma riskSophia S Wang, Mark P Purdue, James R Cerhan, et al.
Gynecologic Oncology|August 16, 2017
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experienceKate E Oliver, William E Brady, Michael Birrer, et al.
Contemporary Clinical Trials|March 8, 2021
Predicting deseasonalised serum 25 hydroxy vitamin D concentrations in the D-Health Trial: An analysis using boosted regression treesMary Waterhouse, Catherine Baxter, Briony Duarte Romero, et al.
JCO Oncology Practice|July 1, 2020
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific ApproachJennifer Y Sheng, Cesar A Santa-Maria, Neha Mangini, et al.
The Journal of Investigative Dermatology|January 16, 2007
CDKN2A germline mutations in individuals with cutaneous malignant melanomaIrene Orlow, Colin B Begg, Javier Cotignola, et al.
Carcinogenesis|November 26, 2008
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphomaMark P Purdue, Qing Lan, Sophia S Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2020
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i> Mutations: Results of the NCI-MATCH Trial Subprotocol HApril K S Salama, Shuli Li, Erin R Macrae, et al.
Breast Cancer Research and Treatment|November 15, 2011
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerMichaela J Higgins, Tatiana M Prowell, Amanda L Blackford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma studyNancy E Thomas, Klaus J Busam, Lynn From, et al.
Pageof 104